StonvexLoading…
StonvexStonvexStonvexCore line items from TCBK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $13.16M | $53.45M | $40.08M | $26.33M |
Operating Income | $45.88M | $166.16M | $119.58M | $73.11M |
Net Income | $33.69M | $121.56M | $87.92M | $53.91M |
EPS (Diluted) | $1.04 | $3.70 | $2.67 | $1.63 |
Total Assets | $9.95B | $9.82B | $9.88B | $9.92B |
Total Liabilities | $8.62B | $8.49B | $8.57B | $8.66B |
Cash & Equivalents | $301.31M | $157.01M | $298.82M | $314.27M |
Free Cash Flow OCF − CapEx | $32.99M | $127.93M | $94.25M | $51.03M |
Shares Outstanding | 31.91M | 32.33M | 32.51M | 32.55M |